TrialJAMA network open2020

Efficacy and Safety of Apatinib Plus Vinorelbine in Patients With Wild-Type Advanced Non-Small Cell Lung Cancer After Second-Line Treatment Failure: A Nonrandomized Clinical Trial.

Xiangyu Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.